Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP and Silymarin for Melasma
NCT05626881Unknown
- Sponsor
- Sohag University
- Start
- May 2022
- Primary completion
- Dec 2022
- Modality
- Hydrogel Systems, Small Molecules, Cell Therapies
- Countries
- 1
01
Overview
Randomised, open-label trial of silymarin and autologous platelet rich gel in melasma, sponsored by Sohag University. Status: unknown.
02
Drugs
silymarinautologous platelet rich gel
03
Conditions
melasma
Beyond the preview
Go deeper on NCT05626881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05626881.